Related Experiment Video
Updated: Jul 17, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
A machine learning model for early risk stratification of 28-day mortality after myocardial infarction
Pierre G Aublin1,2, Stephanie G Kühne2, David Füller3
1Chair for Diagnostic Sensing, University of Augsburg, Eichleitnerstraße 30, 86159, Augsburg, Germany.
Aims:
Despite significant improvement in transcatheter therapies, myocardial infarction (MI) retains a high burden of morbidity and mortality. While several scores have been developed, an established risk model tailored to predict short-term mortality after MI is lacking.
Methods And Results:
In this study, we leveraged real-world data to develop a machine learning (ML) model for predicting 28-day mortality after MI, relying on clinical data collected within the first 24 h of hospitalization. From the Augsburg Myocardial Infarction Registry, 14 725 MI patients surviving the first 24 h of the acute event were included: 80% in the training set for model development to train a Gradient Boosting Machine while the 20% remaining served as test set. A sequential feature selection process retained variables as long as their addition improved AUPRC within 5-fold cross-validation on the train set. We then assessed our model on the test set and performed an external validation on 1328 patients from the Brandenburg Myocardial Infarction Registry. Shapley additive explanations values were used to explain the ML model's predictions. Our model retained six variables including age, systolic blood pressure, admission levels of glucose, creatinine, leucocytes, and whether the patient had a prehospital cardiac arrest. It exhibited good calibration and discrimination ability on the internal (AUROC=0.82) and external validation (AUROC=0.85) and outperformed common scores like GRACE, CADILLAC, and TIMI (P = 0.05).
Conclusion:
The results highlight the potential of our model to ease the detection of patients at high risk, allowing targeted early intervention to improve their outcome, and to contribute to improved precision medicine.